160 related articles for article (PubMed ID: 1251567)
1. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
Vermeer C; Soute BA; Ates G; Brummelhuis HG
Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
[TBL] [Abstract][Full Text] [Related]
2. Improved yields of factor VIII from heparinized plasma.
Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
[TBL] [Abstract][Full Text] [Related]
3. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
Wensley RT; Snape TJ
Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
[TBL] [Abstract][Full Text] [Related]
4. Preparation of cryoprecipitated factor VIII concentrates.
Slichter SJ; Counts RB; Henderson R; Harker LA
Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
[TBL] [Abstract][Full Text] [Related]
5. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
6. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
Farrugia A; Prowse C
J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
[TBL] [Abstract][Full Text] [Related]
7. Contributions to the optimal use of human blood. VIII. Stability of blood coagulation factor VII during collection and storage of whole blood and plasma.
Vermeer C; Soute BA; Ates G; Hellings JA; Brummelhuis HG
Vox Sang; 1976; 31(1 SUPPL):55-67. PubMed ID: 12616
[TBL] [Abstract][Full Text] [Related]
8. Determinants of factor VIII recovery in cryoprecipitate.
Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
[TBL] [Abstract][Full Text] [Related]
9. Characterization of factors affecting the stability of frozen heparinized plasma.
Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
[TBL] [Abstract][Full Text] [Related]
10. Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII.
Margolis J; Rhoades P
Vox Sang; 1979; 36(6):369-74. PubMed ID: 494575
[TBL] [Abstract][Full Text] [Related]
11. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
[TBL] [Abstract][Full Text] [Related]
12. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
13. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
de Wit HJ; Scheer G; Muradin J; van der Does JA
Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
[TBL] [Abstract][Full Text] [Related]
14. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
[TBL] [Abstract][Full Text] [Related]
15. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
Prowse C; Waterston YG; Dawes J; Farrugia A
Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
[TBL] [Abstract][Full Text] [Related]
16. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
[TBL] [Abstract][Full Text] [Related]
17. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
[TBL] [Abstract][Full Text] [Related]
18. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
Hellings JA; Over J; van Mourik JA
Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
[TBL] [Abstract][Full Text] [Related]
19. Variations in cryoprecipitate production.
Rock G; Tittley P
Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
[TBL] [Abstract][Full Text] [Related]
20. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
